Optical Coherence Tomography (OCT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Optical Coherence Tomography (OCT) Pipeline Market Report Overview

Optical Coherence Tomography (OCT) equipment allows for the imaging and measurement of retinal thickness. The Optical Coherence Tomography pipeline market research report provides comprehensive information about the OCT pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Territories ·        The US

·        China

·        Europe

·        Global

·        Japan

Key Regulatory Paths ·        510(k)

·        NMPA

·        UKCA

·        CE

·        Ninsho

Leading Companies ·        Canon USA Inc

·        Compact Imaging Inc.

·        Costruzioni Strumenti Oftalmici Cso Srl

·        Duke University

·        George Washington University

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.a

OCT Pipeline Market Segmentation by Territories

Some of the key territories in the OCT market are China, the United States, Europe, Global, and Japan among others. As of November 2023, the US has the highest number of pipeline products.

OCT Pipeline Market Analysis by Territories, 2023 (%)

OCT Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the OCT Pipeline Market

Download a Free Report Sample

OCT Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the OCT pipeline market are 510(k), NMPA, UKCA, CE, and Ninsho. As of November 2023, 510(k) is the most followed pathway for pipeline products in the market.

OCT Pipeline Market Analysis by Regulatory Paths, 2023 (%)

OCT Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the OCT Pipeline Market

Download a Free Report Sample

OCT Pipeline Market – Competitive Landscape

Some of the key companies in the OCT pipeline market are:

  • Canon USA Inc
  • Compact Imaging Inc.
  • Costruzioni Strumenti Oftalmici Cso Srl
  • Duke University
  • George Washington University

Duke University (Duke): It is an educational institution that provides education and research services. The institute offers undergraduate, graduate, professional, and legal programs. It offers courses in areas of arts and humanities, natural science, social science, law, earth and climate, engineering, history, machine learning and artificial intelligence, psychology, and others. Duke also offers language courses, visual arts, theatre studies, religious studies, culture and romance studies. The institute conducts research in fields of basic science, clinical and translational research, and data science, among others. Its services offerings include financial aid, study abroad, and library services. Duke is headquartered in Durham, North Carolina, the US.

OCT Pipeline Market Analysis by Companies, 2023

OCT Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the OCT Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

OCT Pipeline Market Territories Outlook

  • The US
  • China
  • Europe
  • Global
  • Japan

OCT Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • NMPA
  • UKCA
  • CE
  • Ninsho

Scope

This report provides:

  • Extensive coverage of the OCT under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in pipeline product development and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of OCT under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Canon USA Inc
Compact Imaging Inc.
Costruzioni Strumenti Oftalmici Cso Srl
Duke University
George Washington University
Heidelberg Engineering GmbH
IDx LLC
Kubota Vision Inc
Leica Microsystems GmbH
LighTopTech Corp
Lumedica Inc
MicroPort Scientific Corp
Moorfields Eye Hospital NHS Foundation Trust
Nippon Telegraph and Telephone Corp
Notal Vision Inc
Opticent Inc
OptoQuest Inc
Optos Plc
OptoVibronex LLC
Optovue Inc
Oregon Health & Science University
Physical Sciences Inc
Rowiak GmbH
Singapore Eye Research Institute
Sinoora Inc.
Theia Imaging LLC
Tupai (Beijing) Medical Technology Co Ltd
University of California Berkeley
University of Illinois at Chicago
University of Liverpool
University of Louisville
University of Pittsburgh
University of Rochester
University of Texas at Austin
Vanderbilt University

Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 8

2 Introduction 9

2.1 Optical Coherence Tomography (OCT) Overview 9

3 Products under Development 10

3.1 Optical Coherence Tomography (OCT) – Pipeline Products by Stage of Development 10

3.2 Optical Coherence Tomography (OCT) – Pipeline Products by Territory 11

3.3 Optical Coherence Tomography (OCT) – Pipeline Products by Regulatory Path 12

3.4 Optical Coherence Tomography (OCT) – Pipeline Products by Estimated Approval Date 13

3.5 Optical Coherence Tomography (OCT) – Ongoing Clinical Trials 14

4 Optical Coherence Tomography (OCT) – Pipeline Products under Development by Companies 15

4.1 Optical Coherence Tomography (OCT) Companies – Pipeline Products by Stage of Development 15

4.2 Optical Coherence Tomography (OCT) – Pipeline Products by Stage of Development 17

5 Optical Coherence Tomography (OCT) Companies and Product Overview 19

5.1 Canon USA Inc Company Overview 19

5.1.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.2 Compact Imaging Inc. Company Overview 20

5.2.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 Costruzioni Strumenti Oftalmici Cso Srl Company Overview 21

5.3.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 21

5.4 Duke University Company Overview 22

5.4.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 22

5.5 George Washington University Company Overview 27

5.5.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Heidelberg Engineering GmbH Company Overview 28

5.6.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 IDx LLC Company Overview 30

5.7.1 IDx LLC Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 Kubota Vision Inc Company Overview 31

5.8.1 Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 Leica Microsystems GmbH Company Overview 34

5.9.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

5.10 LighTopTech Corp Company Overview 36

5.10.1 LighTopTech Corp Pipeline Products & Ongoing Clinical Trials Overview 36

5.11 Lumedica Inc Company Overview 37

5.11.1 Lumedica Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.12 MicroPort Scientific Corp Company Overview 39

5.12.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 39

5.13 Moorfields Eye Hospital NHS Foundation Trust Company Overview 40

5.13.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 40

5.14 Nippon Telegraph and Telephone Corp Company Overview 41

5.14.1 Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview 41

5.15 Notal Vision Inc Company Overview 42

5.15.1 Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.16 Opticent Inc Company Overview 46

5.16.1 Opticent Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.17 OptoQuest Inc Company Overview 48

5.17.1 OptoQuest Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.18 Optos Plc Company Overview 49

5.18.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 49

5.19 OptoVibronex LLC Company Overview 52

5.19.1 OptoVibronex LLC Pipeline Products & Ongoing Clinical Trials Overview 52

5.20 Optovue Inc Company Overview 53

5.20.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 53

5.21 Oregon Health & Science University Company Overview 54

5.21.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 54

5.22 Physical Sciences Inc Company Overview 55

5.22.1 Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 55

5.23 Rowiak GmbH Company Overview 56

5.23.1 Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview 56

5.24 Singapore Eye Research Institute Company Overview 57

5.24.1 Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview 57

5.25 Sinoora Inc. Company Overview 58

5.25.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 58

5.26 Theia Imaging LLC Company Overview 59

5.26.1 Theia Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 59

5.27 Tupai (Beijing) Medical Technology Co Ltd Company Overview 62

5.27.1 Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

5.28 University of California Berkeley Company Overview 63

5.28.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 63

5.29 University of Illinois at Chicago Company Overview 64

5.29.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 64

5.30 University of Liverpool Company Overview 65

5.30.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 65

5.31 University of Louisville Company Overview 66

5.31.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 66

5.32 University of Pittsburgh Company Overview 67

5.32.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 67

5.33 University of Rochester Company Overview 68

5.33.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 68

5.34 University of Texas at Austin Company Overview 69

5.34.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 69

5.35 Vanderbilt University Company Overview 70

5.35.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 70

6 Optical Coherence Tomography (OCT)- Recent Developments 71

6.1 Feb 15, 2023: Xoran Technologies Expands Board of Managers 71

6.2 Feb 10, 2023: Carl Zeiss Meditec achieves further revenue growth in First quarter 2022/23 71

6.3 Jan 30, 2023: Topcon Announces Consolidated Financial Results for the Third Quarter of FY2022 Ending March 2023 72

7 Appendix 73

7.1 Methodology 73

7.2 About GlobalData 76

7.3 Contact Us 76

7.4 Disclaimer 76

Table

Optical Coherence Tomography (OCT) – Pipeline Products by Stage of Development 10

Optical Coherence Tomography (OCT) – Pipeline Products by Territory 11

Optical Coherence Tomography (OCT) – Pipeline Products by Regulatory Path 12

Optical Coherence Tomography (OCT) – Pipeline Products by Estimated Approval Date 13

Optical Coherence Tomography (OCT) – Ongoing Clinical Trials 14

Optical Coherence Tomography (OCT) Companies – Pipeline Products by Stage of Development 15

Optical Coherence Tomography (OCT) – Pipeline Products by Stage of Development 17

Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 19

SPOCT HR – Product Status 19

SPOCT HR – Product Description 19

Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 20

MRO Optical Imaging Sensor – Product Status 20

MRO Optical Imaging Sensor – Product Description 20

Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 21

MD-SD-OCT Instrument – Product Status 21

MD-SD-OCT Instrument – Product Description 21

Duke University Pipeline Products & Ongoing Clinical Trials Overview 22

HH – SDOCT – Product Status 22

HH – SDOCT – Product Description 22

Microscope Integrated OCT System – Product Status 23

Microscope Integrated OCT System – Product Description 23

OCT Scanner – Product Status 23

OCT Scanner – Product Description 24

Whole Eye Optical Coherence Tomography Scanner – Product Status 24

Whole Eye Optical Coherence Tomography Scanner – Product Description 24

Duke University – Ongoing Clinical Trials Overview 25

Whole Eye Optical Coherence Tomography Scanner – Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 2 and School Age Follow on Study 26

George Washington University Pipeline Products & Ongoing Clinical Trials Overview 27

Amplified Bimorph Scanning Mirror System – Product Status 27

Amplified Bimorph Scanning Mirror System – Product Description 27

Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 28

Cataract And Refractive Imaging Device – Product Status 28

Cataract And Refractive Imaging Device – Product Description 28

SPECTRALIS OCT2 Module – OCT Angiography – Product Status 29

SPECTRALIS OCT2 Module – OCT Angiography – Product Description 29

IDx LLC Pipeline Products & Ongoing Clinical Trials Overview 30

IDx – Glaucoma – Product Status 30

IDx – Glaucoma – Product Description 30

Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Retinal Health Monitoring OCT System – Product Status 31

Retinal Health Monitoring OCT System – Product Description 31

Kubota Vision Inc – Ongoing Clinical Trials Overview 32

Retinal Health Monitoring OCT System – A Prospective Study of Patient Based Ophthalmology Suite (PBOS), In-home Optical Coherence Tomography Device in Patients of Japan 33

Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

DI-SDOCT Imaging System – Product Status 34

DI-SDOCT Imaging System – Product Description 34

SDOCT Scanner – Product Status 35

SDOCT Scanner – Product Description 35

LighTopTech Corp Pipeline Products & Ongoing Clinical Trials Overview 36

Gabor-Domain Optical Coherence Microscopy Imaging System – Product Status 36

Gabor-Domain Optical Coherence Microscopy Imaging System – Product Description 36

Lumedica Inc Pipeline Products & Ongoing Clinical Trials Overview 37

OCTA System – Product Status 37

OCTA System – Product Description 37

Optical Coherence Tomography System – Product Status 38

Optical Coherence Tomography System – Product Description 38

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 39

New Generation OCT – Product Status 39

New Generation OCT – Product Description 39

Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 40

Binocular Optical Coherence Tomography – Product Status 40

Binocular Optical Coherence Tomography – Product Description 40

Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview 41

High – Speed Wavelength Swept Light – Based OCT Device – Product Status 41

High – Speed Wavelength Swept Light – Based OCT Device – Product Description 41

Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Notal Home OCT System – Product Status 42

Notal Home OCT System – Product Description 42

Notal Vision Inc – Ongoing Clinical Trials Overview 43

Notal Home OCT System – Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision 44

Notal Home OCT System – Home OCT Fluid Visualization Agreement Study at Multiple Retinal Clinics with Placement of One Home OCT Device in the Home of Each NV-AMD Subject in the US for 5 Weeks 44

Notal Home OCT System – Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD 44

Notal Home OCT System – Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD 45

Opticent Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Aurora X3 – Product Status 46

Aurora X3 – Product Description 46

SS-vis-OCT – Product Status 47

SS-vis-OCT – Product Description 47

OptoQuest Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Vectralis – Product Status 48

Vectralis – Product Description 48

Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 49

Falcon I – Product Status 49

Falcon I – Product Description 49

Falcon II – Product Status 50

Falcon II – Product Description 50

Lotte – Product Status 50

Lotte – Product Description 51

OptoVibronex LLC Pipeline Products & Ongoing Clinical Trials Overview 52

OptoScope 2.0 – Product Status 52

OptoScope 2.0 – Product Description 52

Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 53

Intelligent OCT Retinal Disease Screening System – Product Status 53

Intelligent OCT Retinal Disease Screening System – Product Description 53

Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 54

OCTA Test – Product Status 54

OCTA Test – Product Description 54

Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 55

AO-OCT System – Product Status 55

AO-OCT System – Product Description 55

Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview 56

Pencil OCT – Product Status 56

Pencil OCT – Product Description 56

Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview 57

Polarization Sensitive Optical Coherence Tomography (PS-OCT) Device – Product Status 57

Polarization Sensitive Optical Coherence Tomography (PS-OCT) Device – Product Description 57

Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 58

On-chip Spectral Coherence Tomography System – Product Status 58

On-chip Spectral Coherence Tomography System – Product Description 58

Theia Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 59

300 kHz OCT System – Product Status 59

300 kHz OCT System – Product Description 59

Theia 2 System – Product Status 60

Theia 2 System – Product Description 60

Theia T1 System – Product Status 60

Theia T1 System – Product Description 61

Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

Ophthalmic OCT Device – Product Status 62

Ophthalmic OCT Device – Product Description 62

University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 63

Directional Optical Coherence Tomography Device – Product Status 63

Directional Optical Coherence Tomography Device – Product Description 63

University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 64

Multimodal OCT Device – Product Status 64

Multimodal OCT Device – Product Description 64

University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 65

Ultra-Sensitive Optical Coherence Tomography system – Product Status 65

Ultra-Sensitive Optical Coherence Tomography system – Product Description 65

University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 66

Diagnostic System – Diabetic Retinopathy – Product Status 66

Diagnostic System – Diabetic Retinopathy – Product Description 66

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 67

Automated Optic Nerve Head Assessment System – Product Status 67

Automated Optic Nerve Head Assessment System – Product Description 67

University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 68

Scanning Optical System – Product Status 68

Scanning Optical System – Product Description 68

University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 69

Non-Invasive Detection System – Product Status 69

Non-Invasive Detection System – Product Description 69

Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 70

Optical Imaging System – Retinal Disease – Product Status 70

Optical Imaging System – Retinal Disease – Product Description 70

Glossary 75

Figures

Optical Coherence Tomography (OCT) – Pipeline Products by Stage of Development 10

Optical Coherence Tomography (OCT) – Pipeline Products by Territory 11

Optical Coherence Tomography (OCT) – Pipeline Products by Regulatory Path 12

Optical Coherence Tomography (OCT) – Pipeline Products by Estimated Approval Date 13

Optical Coherence Tomography (OCT) – Ongoing Clinical Trials 14

Frequently asked questions

Optical Coherence Tomography (OCT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Optical Coherence Tomography (OCT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Optical Coherence Tomography (OCT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Optical Coherence Tomography (OCT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.